Skip to content
healthcare.dev

Mucus Relief Extended Release

NDC 0536-1163, Guaifenesin, tablet, extended release, from Rugby Laboratories, Inc..

Product NDC
0536-1163
Status
Listed
Labeler
Rugby Laboratories, Inc.
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA207342
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0536-1163 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GUAIFENESIN600 mg/1

Pharmacologic classes

Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]

Package NDCNDC-11Package
0536-1163-6100536116361100 BLISTER PACK in 1 CARTON (0536-1163-61) / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • NADAC price for package 00536116361

    GET /v1/drugs/nadac/00536116361

Use it

Look up 0536-1163 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0536-1163 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0536-1163. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.